Literature DB >> 6389956

Prognosis of adult onset polycystic kidney disease re-evaluated.

D N Churchill, J C Bear, J Morgan, R H Payne, P J McManamon, M H Gault.   

Abstract

To appraise the prognosis of adult onset polycystic kidney disease (APKD), an inception cohort containing 140 subjects from 17 kindreds was assembled. Multiple renal cysts, demonstrable by ultrasonography, or clinical APKD, or both were present in 100 subjects. APKD was predicted in 32 subjects unavailable for ultrasonography and could not be excluded in eight deceased subjects. All had been at risk for endstage renal disease (ESRD) since birth. The probability of either developing ESRD, requiring dialysis or transplantation, or dying was estimated using a time-to-event analysis. The earliest age at which ESRD occurred was 36 years. For those with APKD, the probability of being alive and not having ESRD was 77% by age 50, 57% by age 58, and 52% by age 73 years. Excluding those predicted to have APKD changes these probabilities to 75, 53, and 47%, respectively. The serum creatinine values were less than 1.5 mg/dl for most subjects who had not developed ESRD. The prognosis for subjects with APKD is much better than most reports suggest and can be estimated from the time-to-event data presented.

Entities:  

Mesh:

Year:  1984        PMID: 6389956     DOI: 10.1038/ki.1984.154

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  24 in total

1.  Renal function and healthcare costs in patients with polycystic kidney disease.

Authors:  Krista L Lentine; Huiling Xiao; Gerardo Machnicki; Adrian Gheorghian; Mark A Schnitzler
Journal:  Clin J Am Soc Nephrol       Date:  2010-06-10       Impact factor: 8.237

2.  Adult polycystic kidney disease: knowledge, experience, and attitudes to prenatal diagnosis.

Authors:  K A Hodgkinson; L Kerzin-Storrar; E A Watters; R Harris
Journal:  J Med Genet       Date:  1990-09       Impact factor: 6.318

3.  Genetic and clinical studies in autosomal dominant polycystic kidney disease type 1 (ADPKD1).

Authors:  E Coto; S Aguado; J Alvarez; M J Menéndez Díaz; C López-Larrea
Journal:  J Med Genet       Date:  1992-04       Impact factor: 6.318

4.  Transforming Theory into Preventive Genetics in rural Communities.

Authors:  P W Allderdice; B M Woodland; W H Allderdice
Journal:  Can Fam Physician       Date:  1987-01       Impact factor: 3.275

5.  Adult polycystic kidney disease and linked RFLPs at the alpha globin locus: a genetic study in the South Wales population.

Authors:  L P Lazarou; F Davies; M Sarfarazi; G A Coles; P S Harper
Journal:  J Med Genet       Date:  1987-08       Impact factor: 6.318

6.  Diagnosis of adult polycystic kidney disease by genetic markers and ultrasonographic imaging in a voluntary family register.

Authors:  R G Elles; K A Hodgkinson; N P Mallick; D J O'Donoghue; A P Read; S Rimmer; E A Watters; R Harris
Journal:  J Med Genet       Date:  1994-02       Impact factor: 6.318

7.  The HALT polycystic kidney disease trials: design and implementation.

Authors:  Arlene B Chapman; Vicente E Torres; Ronald D Perrone; Theodore I Steinman; Kyongtae T Bae; J Philip Miller; Dana C Miskulin; Frederic Rahbari Oskoui; Amirali Masoumi; Marie C Hogan; Franz T Winklhofer; William Braun; Paul A Thompson; Catherine M Meyers; Cass Kelleher; Robert W Schrier
Journal:  Clin J Am Soc Nephrol       Date:  2010-01       Impact factor: 8.237

8.  A study of genetic linkage heterogeneity in adult polycystic kidney disease.

Authors:  S T Reeders; M H Breuning; M A Ryynanen; A F Wright; K E Davies; A W King; M L Watson; D J Weatherall
Journal:  Hum Genet       Date:  1987-08       Impact factor: 4.132

9.  DNA testing for live kidney donors at risk for autosomal dominant polycystic kidney disease.

Authors:  Edmund Huang; Millie Samaniego-Picota; Thomas McCune; Joseph K Melancon; Robert A Montgomery; Richard Ugarte; Edward Kraus; Karl Womer; Hamid Rabb; Terry Watnick
Journal:  Transplantation       Date:  2009-01-15       Impact factor: 4.939

Review 10.  Polycystic kidney diseases: from molecular discoveries to targeted therapeutic strategies.

Authors:  O Ibraghimov-Beskrovnaya; N Bukanov
Journal:  Cell Mol Life Sci       Date:  2008-02       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.